1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2016

Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 92 pages

Includes 3 FREE quarterly updates

BMI View: Over the forthcoming years, growth in Saudi Arabia's pharmaceutical and healthcare marketswill remain elevated. The government's ongoing commitment to sector development will continue to attractinvestments from multinational drugmakers and healthcare companies. More recently, the Kingdom hasattracted significant attention from the South Korean healthcare industry. Saudi Arabia's economicdiversification plans, dubbed 'Vision 2030', include a promising long-term healthcare strategy. Theprolonged period of subdued oil prices and regional instabilities present downside risks to our otherwisepositive outlook.

Headline Expenditure Projections

- Pharmaceuticals: SAR31.75bn (USD8.46bn) in 2015 to SAR35.33bn (USD9.42bn) in 2016; +11.3% inboth local currency and US dollar terms. Forecast unchanged from Q216.

- Healthcare: SAR142.93bn (USD38.11bn) in 2015 to SAR153.60bn (USD40.94bn) in 2016; +7.5% inlocal currency terms (+7.4% US dollar terms). Forecast in line with Q216.

Table Of Contents

Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Saudi Arabia 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 25
OTC Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2014-2020) 31
Industry Risk Reward Index 32
Middle East and Africa Risk/Reward Index - Q3 2016 32
Saudi Arabia Risk/Reward Index 40
Rewards 40
Risks 40
Regulatory Review 42
Intellectual Property Issues 44
Pricing Regime 46
Reimbursement Regime 48
Market Overview 49
Healthcare Sector 50
Table: Healthcare Resources (Saudi Arabia 2010-2015) 54
Table: Healthcare Personnel (Saudi Arabia 2010-2015) 54
Table: Healthcare Activity (Saudi Arabia 2010-2015) 55
Research and Development 55
Clinical Trials 57
Epidemiology 58
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Market Activity 63
Generic Drugmakers 65
Pharmaceutical Distribution 66
Pharmaceutical Retail Sector 67
Company Profile 68
GlaxoSmithKline 68
Sanofi 71
SPIMACO 74
TABUK Pharmaceutical Manufacturing 78
Demographic Forecast 81
Demographic Outlook 81
Table: Population Headline Indicators (Saudi Arabia 1990-2025) 82
Table: Key Population Ratios (Saudi Arabia 1990-2025) 82
Table: Urban/Rural Population and Life Expectancy (Saudi Arabia 1990-2025) 83
Table: Population By Age Group (Saudi Arabia 1990-2025) 83
Table: Population By Age Group % (Saudi Arabia 1990-2025) 84
Glossary 86
Methodology 88
Pharmaceutical Expenditure Forecast Model 88
Healthcare Expenditure Forecast Model 88
Notes On Methodology 89
Risk/Reward Index Methodology 90
Index Overview 91
Table: Pharmaceutical Risk/Reward Index Indicators 91
Indicator Weightings 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.